6226 Organometallics, Vol. 28, No. 21, 2009
Elowe et al.
1
vial. LiHBEt3 (1 M in THF, 10 μL, 1 equiv) was syringed in to
give a yellow solution. Solvent was evaporated to give the crude
formyl species and LiBPh4 byproduct as a yellow residue. The
residue was dissolved in CD2Cl2 (0.4 mL) and transferred to a
J-Young NMR tube, and the solution frozen in the cold well.
SiMe3OTf (2 μL, 0.01 mmol, 1 equiv) was dissolved in CD2Cl2
(0.3 mL) and the resulting solution added to the J-Young tube
and frozen in the cold well. The contents of the tube were kept at
LN2 temperature until ready to be placed into the NMR probe,
where it was thawed and shaken vigorously to give a yellow
(C(O)CH2OCH3) (cis-13): H NMR (RT, 300 MHz, C6D6): δ
3.17 (3H, s, OCH3), 3.60 (2H, s, CH2), 6.98-7.07 (m, ArH),
7.35-7.44 (m, ArH), 7.59-7.67 (m, ArH). 13C NMR (RT, 126
MHz, C6D6): 58.9 (s, OCH3), 90.5 (d, JC-P = 3.0 Hz, CH2),
128.6, 130.8, 134.0, 135.1, 215.0 (CO), 215.6 (CO), 217.7 (CO),
272.3 (dt, JC-P=16.2 Hz, JC-C=3.5 Hz, C(O)CH2OCH3). 31
P
,
NMR (RT, 121 MHz, C6D6): 53.5 ppm (s, br). IR CO (cm-1
CH2Cl2): 2070, 1994, 1962, 1920, 1624. HRMS (FABþ): m/z for
C25H21MnO6P (M þ H) 503.0456, found 503.0465. trans-Mn-
(PPh3)(CO)4(C(O)CH2OCH3) (trans-13): 1H NMR (RT, 300
MHz, C6D6): 3.27 (3H, s, OCH3), 3.94 (2H, s, CH2), 6.98-7.07
(m, ArH), 7.71-7.80 (m, ArH), 7.80-7.88 (m, ArH). 13C NMR
(RT, 126 MHz, C6D6): 59.1 (s, OCH3), 91.6 (d, JC-P=4.6 Hz,
CH2), 128.8, 132.7, 135.6, 263.4 (br, C(O)CH2OCH3), The
carbonyl ligand signals could not be assigned, as they overlap
with other peaks. IR νCO (cm-1, CH2Cl2): 1636, other stretches
could not be assigned due to overlap.
1
solution. H NMR (RT, 300 MHz, CD2Cl2): δ -0.09 (9H, s,
OSi(CH3)3), 6.83-6.90 (4H, m, B(C6H5)4), 6.98-7.07 (8H, m,
B(C6H5)4), 7.27-7.36 (8H, m, B(C6H5)4), 7.37-7.47 (12H, m,
Ar-H), 7.48-7.56 (18H, m, ArH), 13.91 (1H, s, CHOSiMe3).
31P NMR (RT, 121 MHz, CD2Cl2): 11.3 ppm (s).
Mn(CO)3(PPh3)2(CH2OCH3) (9). In a vial, [Mn(CO)3(PPh3)2-
(CHOMe)][OTf] (40 mg, 0.047 mmol) was suspended in THF
(2 mL). LiHBEt3 (1 M in THF, 47 μL, 1 equiv) was syringed into
the vial. After 2 min of mixing followed by filtration, the resulting
yellow solution was placed into a small vial, which was in turn
placed in a larger vial containing petroleum ether (5 mL) for
crystallization by diffusion. After 15 h the resulting long yellow
needles were decanted, washed with petroleum ether, and dried
under vacuum to give 25 mg (0.036 mmol, 76% yield) of 9. Anal.
Calcd for C41H35MnO4P2: C, 69.20; H, 5.38. Found: C, 68.96; H,
5.17. 1H NMR (RT, 300 MHz, C6D6): δ 2.73 (3H, s, OCH3), 3.60
General Procedure for NMR-Scale Addition of Electrophiles to
Mn(PPh3)(CO)4(COCH2OCH3) (13). In the drybox 15 mg
(0.030 mmol) of Mn(PPh3)(CO)4(COCH2OCH3) (13) was
added to a vial. To the vial was added 0.6 mL of CD2Cl2
followed by 0.030 mmol of the desired electrophile. The solution
was pipetted into a J-Young NMR tube, and disappearance of
cis-13 and appearance of products monitored by H and 31P
1
NMR.
Methylation of 13 with MeOTf. MeOTf (3.4 uL, 4.9 mg, 0.030
mmol) was added, leading to formation of 14 and trans-1,2-
dimethoxyethene over time.
Ethylation of 13 with EtOTf. EtOTf (3.9 uL, 5.3 mg, 0.030
mmol) was added, leading to formation of 14 and trans-1-
ethoxy-2-methoxyethene over time.
3
(2H, t, JH-P = 7.6 Hz, CH2), 6.93-7.01 (6H, m, Ar-H),
7.02-7.11 (12H, m, Ar-H), 7.87-7.97 (12H, m, Ar-H). 13C
NMR (RT, 126 MHz, CD2Cl2): 63.8 (s, OCH3), 75.3 (t, JC-P=
12.9 Hz, CH2OMe), 128.6 (t, JC-P=4.6 Hz, Ar), 129.9 (s, Ar),
133.9 (t, JC-P=5.1 Hz, Ar) 136.7 (m, Ar), 222.8 (t, JC-P=17.8 Hz,
trans CO), 224.4 (t, JC-P=21.3 Hz, cis CO’s). 31P NMR (RT, 121
MHz, C6D6): 76.6 ppm (s). 19F NMR (RT, 471 MHz, C6D6): no
signal, confirming the absence of OTf-. IR: νCO (cm-1, CH2Cl2)
2009, 1921, 1885.
Ethylation of 13 with [Et3O][BF4]. [Et3O][BF4] (5.7 mg 0.030
mmol) was added, leading to formation of 15 and ultimately
trans-1-ethoxy-2-methoxyethene over time. Spectroscopic data
for [Mn(PPh3)(CO)4(C(OEt)CH2OCH3) (15): 1H NMR (RT,
300 MHz, CD2Cl2): δ 7.5 (15H, m, Ph); 4.28 (2H, q, 3JH-H=7
Hz, OCH2CH3); 4.12 (2H, s, CH2OCH3); 3.68 (3H, s, OCH3);
cis-Mn(CO)4(PPh3)(CH2OCH3) (10). In the glovebox, Na/
Hg (0.5 wt %, 4 equiv) was prepared in a flask. A THF (20 mL)
solution of Mn(PPh3)(CO)4Br (388 mg, 0.762 mmol) was slowly
added onto the amalgam. The mixture was allowed to stir in the
absence of light for 2 h. In another flask, ClCH2OCH3 (58 μL, 1
equiv) was dissolved in THF (10 mL) and placed in a Schlenk
tube. On the Schlenk line, the manganese solution was decanted
into the ClCH2OCH3 solution using a filter-tipped cannula. The
mixture was allowed to stir in the absence of light for 2 h, after
which all volatiles were removed. The residue was dissolved in
THF, filtered, recrystallized from THF/petroleum ether, and
dried under vacuum to give 319 mg (0.670 mmol, 88%) of 10 as a
yellow crystalline solid. 1H NMR (RT, 300 MHz, C6D6): δ 3.11
1.36 (3H, t, JH-H = 7 Hz, OCH2CH3). 31P NMR (RT, 121
3
MHz, C6D6): 52.2 (s, br).
Protonation of 13 with HOTf. HOTf (2.7 uL, 4.5 mg, 0.030
mmol) was added, leading to formation of 18 and ultimately 14
and methyl acetate over time.
Formation of Mn(PPh3)(CO)4(C(OEt)dCHOCH3) (16). In
the drybox 30 mg (0.060 mmol) of 13 and 11.4 mg (0.0600 mmol)
of [Et3O][BF4] were added to a vial. To the vial was added 0.6
mL of CD2Cl2. The solution was shaken, then pipetted into a
J-Young NMR tube, and the reaction was monitored by 1H and
31P NMR. When the alkoxycarbene 15 was at its maximum
concentration (∼ 6 h), triethylamine (11 uL, 7.9 mg, 7.8 mmol,
1.3 equiv) was added to the solution. 1H NMR (RT, 300 MHz,
3
(3H, s, OCH3), 3.90 (2H, d, JH-P=7.0 Hz, CH2), 6.93-7.02
(9H, m, Ar-H), 7.50-7.59 (6H, m, Ar-H). 13C NMR (RT,
126 MHz, CD2Cl2): 63.4 (s, OCH3), 71.1 (t, JC-P =11.7 Hz,
CH2OMe), 128.8 (d, JC-P =9.5 Hz, Ar), 130.6 (s, Ar), 133.4
(d, JC-P =10.4 Hz, Ar) 133.8 (d, JC-P =40.3 Hz, Ar), 215.7
(CO), 218.4 (d, JC-P = 21.8 Hz, CO), 218.8 (CO). 31P NMR
(RT, 121 MHz, C6D6): 61.2 ppm (s). HRMS (FABþ): m/z
calcd for C24H23MnO5P (M þ H - H2) 473.0351, found
473.0373.
4
CD2Cl2): δ 7.5 (15H, m, Ph); 6.35 (1H, d, JP-H = 2.7 Hz,
CdCH); 3.49 (3H, s, OMe); 3.17 (2H, q, JH-H = 7 Hz,
3
OCH2CH3); 0.75 (3H, t, 3JH-H=7 Hz, OCH2CH3). 31P NMR
(RT, 121 MHz, C6D6): 54.3 (s, br).
Synthesis of Mn(PPh3)(CO)4(CH2COOCH3) (18). In the dry-
box 500 mg (0.982 mmol) of Mn(PPh3)(CO)4Br was added to a
vial and dissolved in THF. This solution was pipetted into a
flask containing a Na/Hg amalgam (0.5%, 4 equiv), and the
mixture was stirred for 2 h. In a separate flask 287.5 mg (1.178
mmol, 1.2 equiv) of methyl 2-(tosyloxy)acetate was dissolved in
THF. The solution of [Na][Mn(PPh3)(CO)4] was filtered
through Celite into the flask containing methyl 2-(tosyloxy)ace-
tate. The mixture was stirred overnight before being filtered
through Celite, dried in vacuo, and triturated with pentane to
yield 420 mg (0.837 mmol, 85%) of 18. X-ray quality crystals
were obtained by layering a toluene solution of 18 with pentane
and placing in a -35 °C freezer overnight. 1H NMR (RT, 300
MHz, C6D6): δ 7.47 (6H, m, Ph); 6.93 (9H, m, Ph); 3.63 (3H, s,
OMe); 1.36 (2H, d, 3JP-H=7.2 Hz, CH2). 31P NMR (RT, 121
MHz, C6D6): 57.9 (s, br).
Carbonylation of Mn(CO)3(PPh3)2(CH2OCH3) (10) to Form
13. To a flask was added Mn(CO)3(PPh3)2(CH2OCH3) (150 mg,
0.212 mmol) followed by C6H6 (20 mL). The flask was degassed
on the Schlenk line and then filled with CO (1 atm). The flask
was sealed and allowed to stir for 7 days protected from light.
After removing all volatiles, the resulting yellow oil was tritu-
rated several times with hexanes and dried in vacuo to give 140
mg (0.197 mmol, 93%) of a yellow solid. The composition of the
solid is a mixture containing cis-Mn(PPh3)(CO)4(C(O)CH2-
OCH3) (cis-13) (80%), trans-Mn(PPh3)(CO)4(C(O)CH2OCH3)
(trans-13) (13%), and Mn(PPh3)(CO)4(CH2OCH3) (10) (7%). If
the same procedure is followed but CH3OH is used instead of
C6H6, the reaction is complete overnight. cis-Mn(PPh3)(CO)4-